Main Street Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Main Street Group’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$252	Sell	6 -100	-94%	-$3.19K	﹤0.01%	800
2026 Q1	$2.8K	Buy	+106	New	+$3.1K	﹤0.01%	710
2025 Q4	–	Sell	-6	Closed	-$167	–	121
2025 Q3	$167	Hold	6	–	–	﹤0.01%	774
2025 Q2	$146	Hold	6	–	–	﹤0.01%	754
2025 Q1	$125	Hold	6	–	–	﹤0.01%	765
2024 Q4	$142	Hold	6	–	–	﹤0.01%	742
2024 Q3	$154	Hold	6	–	–	﹤0.01%	747
2024 Q2	$139	Hold	6	–	–	﹤0.01%	844
2024 Q1	$170	Hold	6	–	–	﹤0.01%	878
2023 Q4	$196	Buy	+6	New	+$163	﹤0.01%	1242

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Main Street Group's ARKG Position: Q2 2026 in Review

Main Street Group reduced its ARK Genomic Revolution ETF (ARKG) stake by 94% in Q2 2026, selling an estimated $3.19K and leaving 6 shares worth $252. The position accounts for ﹤0.01% of the portfolio, ranked #800.

Main Street Group first reported a position in ARKG in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.8K in Q1 2026. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Main Street Group held 6 shares of ARK Genomic Revolution ETF worth $252 as of Q2 2026.
Main Street Group sold 100 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $3.19K.
ARK Genomic Revolution ETF made up ﹤0.01% of Main Street Group's portfolio in Q2 2026, its #800 holding.
Main Street Group first reported a position in ARK Genomic Revolution ETF in Q4 2023 and has held it in 10 quarters since.
Main Street Group's ARK Genomic Revolution ETF position peaked at $2.8K in Q1 2026.
272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.